Theaflavins are poorly absorbed black tea pigments that act mainly in the gut, blocking some fat, cholesterol, and starch absorption and shifting gut bacteria. Human evidence is thin and mixed; the best-known claim, lowering bad cholesterol, stays uncertain. Safety looks benign, with reduced iron absorption the main caution. A low-risk, low-cost, modest add-on to diet. (Full Review)

Protocol

Dose

375 mg/day

Dose of the positive cholesterol trial; research range ~75–700 mg/day

Timing

With main meal

Taken with the largest fat- and carbohydrate-containing meal

Form

Standardized extract

Black tea extract standardized to a fixed theaflavin %, once daily with a meal

Time to effect

Cholesterol

4–12 weeks

Lipid changes measured over several weeks of daily use

Vascular function

Single dose

Microvascular response improved acutely in volunteers

Body composition

~10 weeks

Body-fat improvement in a 10-week pilot

Benefits

Medium: Reduced LDL cholesterol; antioxidant activity and reduced LDL oxidation

Low: Endothelial and microvascular function; healthy body composition; oral and periodontal health; reduced post-meal absorption of fat, cholesterol, and starch

Speculative: Anti-cancer activity; antiviral and antimicrobial effects; gut microbiome and metabolic syndrome modulation; longevity and senescent-cell signaling

Contraindications

Iron-deficiency anemia or low ferritin (<30 ng/mL)

Pregnancy or breastfeeding

Active liver disease

Nadolol or narrow-therapeutic-index transporter-dependent drugs

Surgery within ~2 weeks

Key Interactions

Iron supplements and iron-rich meals

Anticoagulant and antiplatelet drugs (warfarin, aspirin, clopidogrel)

Over-the-counter medications

Additive lipid-lowering supplements (plant sterols, soluble fibers, red yeast rice, berberine)

Additive antiplatelet/antioxidant supplements (fish oil, garlic, ginkgo, vitamin E)

Caffeine (whole black tea, not most extracts)

Risk & Side Effects

Medium: Reduced non-heme iron absorption; gastrointestinal discomfort

Low: Transient hemodynamic changes; reduced absorption of some nutrients and drugs

Speculative: Pro-oxidant effects at high concentrations; potential liver strain with concentrated extracts

Monitoring

Marker	Target	Why
LDL-C	< 100 mg/dL; often < 70–80 mg/dL for higher-risk optimizers	Primary target of the main claimed benefit
Total cholesterol	< 180 mg/dL	Tracks overall lipid response
HDL-C	> 50 mg/dL (women), > 45–50 mg/dL (men)	Ensures lipid changes are not lowering protective cholesterol
Triglycerides	< 100 mg/dL (functional); < 150 mg/dL (conventional)	Reflects diet and metabolic response
Ferritin	50–150 ng/mL; caution if < 30 ng/mL	Detects reduced iron status from iron binding
ALT / AST	ALT < 25 U/L (women), < 30 U/L (men)	Screens for rare liver strain with high-dose extracts
hs-CRP	< 1.0 mg/L	Optional; tracks any anti-inflammatory effect

Cadence: Lipid panel at 8–12 weeks then every 6–12 months; ferritin at 3–6 months in at-risk users; liver enzymes every 6–12 months with high-dose use

Qualitative Assessment

Digestive comfort (absence of nausea or cramping after dosing)
Energy levels and general sense of well-being
Tolerability at the chosen dose and timing
Absence of easy bruising or bleeding (relevant if combined with blood thinners)

Theaflavins for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment